alphaveANUHPHR₹91.70

Anuh Pharma Limited

₹ CrorePeersAHCL WANBURY ZIMLAB BAJAJHCARE THEMISMED LINCOLN VALIANTLAB SIGACHIMcap ₹919 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	49.6	48.0	48.0
+ Capital Work-in-Progress	0.3	0.0	0.0
+ Other Intangibles	8.6	8.6	8.6
+ Non-current Investments	52.0	39.6	39.6
+ Long-term Loans	0.2	0.1	0.1
+ Other Non-current Financial Assets	15.8	5.8	5.8
Non-current Financial Assets	67.9	45.5	45.5
+ Deferred Tax Assets	2.1	3.9	3.9
+ Other Non-current Assets	2.0	0.1	0.1
Total Non-current Assets	130.5	106.1	106.1
Current Assets
+ Inventories	74.5	147.8	147.8
+ Current Investments	53.9	44.9	44.9
+ Trade Receivables	215.9	238.6	238.6
+ Cash & Cash Equivalents	19.6	8.1	8.1
+ Other Bank Balances	0.2	0.2	0.2
+ Short-term Loans	0.5	0.8	0.8
+ Other Current Financial Assets	0.3	0.9	0.9
Current Financial Assets	290.3	293.6	293.6
+ Other Current Assets	11.4	10.0	10.0
Total Current Assets	376.2	451.3	451.3
Total Assets	506.6	557.4	557.4
Equity
+ Equity Share Capital	25.1	50.1	50.1
+ Other Equity / Reserves	301.0	302.1	302.1
Equity — Owners of Parent	326.0	352.2	352.2
Total Equity	326.0	352.2	352.2
Liabilities
+ Other Non-current Financial Liab	0.1	—	—
Non-current Financial Liabilities	0.1	0.0	0.0
+ Provisions — Non-current	2.0	2.1	2.1
Non-current Liabilities	2.1	2.1	2.1
+ Borrowings — Current	10.5	0.0	0.0
+ Trade Payables	156.8	187.7	187.7
+ Other Current Financial Liab	7.3	7.7	7.7
Current Financial Liabilities	174.6	195.4	195.4
+ Provisions — Current	0.2	0.3	0.3
+ Current Tax Liabilities	0.5	2.3	2.3
+ Other Current Liabilities	3.2	5.0	5.0
Current Liabilities	178.5	203.0	203.0
Total Liabilities	180.6	205.1	205.1
Total Equity & Liabilities	506.6	557.4	557.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	1.4	2.3	2.3
+ Dues to Other Creditors — Current	155.4	185.3	185.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.